Dumadaug, Eriberto F.

HRN: 21-56-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFTAZIDIME 1GM (VIAL)
06/18/2022
06/25/2022
IV
1 Gram
Q8hours
CAP MR With Concomittant PTB, Relapse
Waiting Final Action 
06/18/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/18/2022
06/22/2022
ORAL
500mg
OD
CAP-MR With Concomittant PTB Relapse
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: